MA, R., KANG, X., ZHANG, G., FANG, F., DU, Y., & LV, H. (2016). High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma. Oncology Letters, 11(3), 2300. https://doi.org/10.3892/ol.2016.4171
Chicago Style (17th ed.) CitationMA, RUIMIN, XIXIONG KANG, GUOJUN ZHANG, FANG FANG, YAMEI DU, and HONG LV. "High Expression of UBE2C Is Associated with the Aggressive Progression and Poor Outcome of Malignant Glioma." Oncology Letters 11, no. 3 (2016): 2300. https://doi.org/10.3892/ol.2016.4171.
MLA (9th ed.) CitationMA, RUIMIN, et al. "High Expression of UBE2C Is Associated with the Aggressive Progression and Poor Outcome of Malignant Glioma." Oncology Letters, vol. 11, no. 3, 2016, p. 2300, https://doi.org/10.3892/ol.2016.4171.